Abstract
To the Editor: We read with interest the report by Toussirot1 describing another case of psoriasis emerging in a patient treated with rituximab (RTX) for rheumatoid arthritis. The case described has some similarities to the woman whose case we recently reported2 in that it involves plaque psoriasis developing after a first course of RTX. However, there are a number of important differences. Whereas our patient was seronegative with a positive family history and previous episode of guttate … Address correspondence to Dr. S. Hardcastle, Academic Rheumatology, Musculoskeletal Research Unit, Avon Orthopaedic Centre, Southmead Hospital, Bristol BS10 5NB, UK., E-mail: Sarah.Hardcastle{at}bristol.ac.uk
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
